Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.

Saved in:
Bibliographic Details
Title: Effects of MetAP2 inhibition on hyperphagia and body weight in Prader-Willi syndrome: A randomized, double-blind, placebo-controlled trial.
Authors: McCandless, Shawn E.1, Yanovski, Jack A.2, Miller, Jennifer3, Fu, Cary4, Bird, Lynne M.5, Salehi, Parisa6, Chan, Christine L.7, Stafford, Diane8, Abuzzahab, M. Jennifer9, Viskochil, David10, Barlow, Sarah E.11, Angulo, Moris12, Myers, Susan E.13, Whitman, Barbara Y.13, Styne, Dennis14, Roof, Elizabeth4, Dykens, Elisabeth M.4, Scheimann, Ann O.15, Malloy, Jaret16, Zhuang, Dongliang16
Source: Diabetes, Obesity & Metabolism. Dec2017, Vol. 19 Issue 12, p1751-1761. 11p.
Database: Academic Search Ultimate
Description
ISSN:14628902
DOI:10.1111/dom.13021